Company Filing History:
Years Active: 2019
Title: David Farrington: Innovator in Pharmaceutical Compositions
Introduction
David Farrington is a notable inventor based in Garden City, NY (US). He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of pulmonary infections. His innovative work focuses on enhancing the efficacy of medications through advanced formulations.
Latest Patents
Farrington holds a patent for "Micronized colistimethane sodium pharmaceutical compositions." This patent describes micronized powder particles of colistimethate sodium, wherein at least 50% by volume of the micronized particles have a diameter of less than 7 micrometers but not less than 3 micrometers. The powder has a total moisture content of 5 to 10% by weight, making it suitable for treating pulmonary infections through powder inhalation. This formulation is particularly beneficial for patients suffering from cystic fibrosis, as it targets infections caused by gram-negative bacteria.
Career Highlights
David Farrington is associated with Actavis Group Ptc Ehf, a company known for its commitment to developing high-quality pharmaceutical products. His work at Actavis has allowed him to focus on innovative solutions that address critical health issues.
Collaborations
Farrington has collaborated with notable colleagues, including Richard Anthony Flynn and Rahul Surana. These partnerships have contributed to the advancement of pharmaceutical research and development.
Conclusion
David Farrington's contributions to pharmaceutical compositions demonstrate his commitment to improving patient care through innovation. His work continues to impact the treatment of pulmonary infections, showcasing the importance of advancements in medical science.